Today: 29 April 2026
Browse Category

TSX:6146 6 November 2025 - 22 January 2026

Dow snaps back after Trump cools Greenland tariff threat; Asia rallies and gold slips from record

Dow snaps back after Trump cools Greenland tariff threat; Asia rallies and gold slips from record

Wall Street posted its strongest session in two months Wednesday after President Trump dropped tariff threats linked to Greenland, sending the S&P 500 up 1.16% and the Dow higher by 588 points. Asian markets followed, with South Korea’s Kospi briefly topping 5,000. Gold retreated from record highs as volatility eased. European shares and the euro also gained as investors awaited central bank decisions and key earnings.
22 January 2026
······
Tokyo Stock Market’s Biggest Gainers Today (December 9, 2025): Chip Makers, Industrials and Utilities Drive the Nikkei 225 Higher

Tokyo Stock Market’s Biggest Gainers Today (December 9, 2025): Chip Makers, Industrials and Utilities Drive the Nikkei 225 Higher

Tokyo’s Nikkei 225 closed near 50,700, up 0.2% after a volatile session led by gains in semiconductor and factory-automation stocks including Disco and Fanuc. Energy and auto-related shares such as TEPCO and Yokohama Rubber also advanced. Investors remained cautious ahead of a possible U.S. Federal Reserve rate cut and a Bank of Japan policy meeting later this month.
9 December 2025
·········
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

Japan Stocks Today (Nov 6, 2025): Nikkei 225 Rebounds Above 50,800 as Tech and Banks Lead; Yen Holds Near ¥154

The Nikkei 225 jumped 1.3% to 50,883.68 on Thursday, with chip stocks Advantest, Disco, and Lasertec leading gains after Wall Street’s rebound. Market breadth improved, with 987 advancers on the TSE Prime. The yen hovered near 153.8 to the dollar, and the 10-year JGB yield stayed close to 1.68%. Toyota reported a 7% profit drop, while Nissan posted a ¥221.9bn first-half loss.
6 November 2025
·····

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. (marketscreener.com) The revision matters because Biogen is
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop